These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 22698944)

  • 1. An inhalable β₂-adrenoceptor ligand-directed guanidinylated chitosan carrier for targeted delivery of siRNA to lung.
    Luo Y; Zhai X; Ma C; Sun P; Fu Z; Liu W; Xu J
    J Control Release; 2012 Aug; 162(1):28-36. PubMed ID: 22698944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Chitosan-siRNA complex nanoparticles for gene silencing].
    Liu X
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2010 Feb; 27(1):97-101. PubMed ID: 20337033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonviral pulmonary delivery of siRNA.
    Merkel OM; Kissel T
    Acc Chem Res; 2012 Jul; 45(7):961-70. PubMed ID: 21905687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of polymeric properties on chitosan/siRNA nanoparticle formulation and gene silencing.
    Liu X; Howard KA; Dong M; Andersen MØ; Rahbek UL; Johnsen MG; Hansen OC; Besenbacher F; Kjems J
    Biomaterials; 2007 Feb; 28(6):1280-8. PubMed ID: 17126901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nebulized anionic guanidinylated O-carboxymethyl chitosan/N-2-hydroxypropyltimehyl ammonium chloride chitosan nanoparticles for siRNA pulmonary delivery: preparation, characterization and in vitro evaluation.
    Ni S; Xie Y; Tang Y; Liu Y; Chen J; Zhu S
    J Drug Target; 2017 Jun; 25(5):451-462. PubMed ID: 28110554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The suppression of lung tumorigenesis by aerosol-delivered folate-chitosan-graft-polyethylenimine/Akt1 shRNA complexes through the Akt signaling pathway.
    Jiang HL; Xu CX; Kim YK; Arote R; Jere D; Lim HT; Cho MH; Cho CS
    Biomaterials; 2009 Oct; 30(29):5844-52. PubMed ID: 19640582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chitosan as a carrier for targeted delivery of small interfering RNA.
    Rudzinski WE; Aminabhavi TM
    Int J Pharm; 2010 Oct; 399(1-2):1-11. PubMed ID: 20732398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chitosan nanoparticle as gene therapy vector via gastrointestinal mucosa administration: results of an in vitro and in vivo study.
    Zheng F; Shi XW; Yang GF; Gong LL; Yuan HY; Cui YJ; Wang Y; Du YM; Li Y
    Life Sci; 2007 Jan; 80(4):388-96. PubMed ID: 17074366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RNAi using a chitosan/siRNA nanoparticle system: in vitro and in vivo applications.
    Andersen MØ; Howard KA; Kjems J
    Methods Mol Biol; 2009; 555():77-86. PubMed ID: 19495689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. siRNA delivery with chitosan nanoparticles: Molecular properties favoring efficient gene silencing.
    Malmo J; Sørgård H; Vårum KM; Strand SP
    J Control Release; 2012 Mar; 158(2):261-8. PubMed ID: 22119955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative in vivo study of poly(ethylene imine)/siRNA complexes for pulmonary delivery in mice.
    Beyerle A; Braun A; Merkel O; Koch F; Kissel T; Stoeger T
    J Control Release; 2011 Apr; 151(1):51-6. PubMed ID: 21223987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphorylatable short peptide conjugated low molecular weight chitosan for efficient siRNA delivery and target gene silencing.
    Kong F; Liu G; Sun B; Zhou S; Zuo A; Zhao R; Liang D
    Int J Pharm; 2012 Jan; 422(1-2):445-53. PubMed ID: 22067703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polyethylenimines for RNAi-mediated gene targeting in vivo and siRNA delivery to the lung.
    Günther M; Lipka J; Malek A; Gutsch D; Kreyling W; Aigner A
    Eur J Pharm Biopharm; 2011 Apr; 77(3):438-49. PubMed ID: 21093588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and characterisation of chitosan nanoparticles for siRNA delivery.
    Katas H; Alpar HO
    J Control Release; 2006 Oct; 115(2):216-25. PubMed ID: 16959358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced siRNA delivery and silencing gold-chitosan nanosystem with surface charge-reversal polymer assembly and good biocompatibility.
    Han L; Zhao J; Zhang X; Cao W; Hu X; Zou G; Duan X; Liang XJ
    ACS Nano; 2012 Aug; 6(8):7340-51. PubMed ID: 22838646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Poly(beta-amino ester) as a carrier for si/shRNA delivery in lung cancer cells.
    Jere D; Xu CX; Arote R; Yun CH; Cho MH; Cho CS
    Biomaterials; 2008 Jun; 29(16):2535-47. PubMed ID: 18316120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chitosan-graft-polyethylenimine for Akt1 siRNA delivery to lung cancer cells.
    Jere D; Jiang HL; Kim YK; Arote R; Choi YJ; Yun CH; Cho MH; Cho CS
    Int J Pharm; 2009 Aug; 378(1-2):194-200. PubMed ID: 19501140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Naked siLNA-mediated gene silencing of lung bronchoepithelium EGFP expression after intravenous administration.
    Glud SZ; Bramsen JB; Dagnaes-Hansen F; Wengel J; Howard KA; Nyengaard JR; Kjems J
    Oligonucleotides; 2009 Jun; 19(2):163-8. PubMed ID: 19441893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histological Quantification of Gene Silencing by Intratracheal Administration of Dry Powdered Small-Interfering RNA/Chitosan Complexes in the Murine Lung.
    Ihara D; Hattori N; Horimasu Y; Masuda T; Nakashima T; Senoo T; Iwamoto H; Fujitaka K; Okamoto H; Kohno N
    Pharm Res; 2015 Dec; 32(12):3877-85. PubMed ID: 26138669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A biomimetic nanovector-mediated targeted cholesterol-conjugated siRNA delivery for tumor gene therapy.
    Ding Y; Wang W; Feng M; Wang Y; Zhou J; Ding X; Zhou X; Liu C; Wang R; Zhang Q
    Biomaterials; 2012 Dec; 33(34):8893-905. PubMed ID: 22979990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.